XML 164 R117.htm IDEA: XBRL DOCUMENT v2.4.1.9
Restructuring and Other - Activity in Recorded Workforce Reduction Liabilities (Detail) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Restructuring Reserve [Roll Forward]        
Beginning balance   $ 39,104us-gaap_RestructuringReserve $ 15,898us-gaap_RestructuringReserve $ 4,780us-gaap_RestructuringReserve
Workforce reduction charges 33,400us-gaap_SeveranceCosts1 1,948us-gaap_SeveranceCosts1 [1] 33,361us-gaap_SeveranceCosts1 [1],[2] 21,640us-gaap_SeveranceCosts1 [1]
Payments   (35,139)us-gaap_PaymentsForRestructuring (8,915)us-gaap_PaymentsForRestructuring (10,929)us-gaap_PaymentsForRestructuring
Amount reversed to income   (1,200)us-gaap_RestructuringReserveAccrualAdjustment [3] (1,209)us-gaap_RestructuringReserveAccrualAdjustment [3] (45)us-gaap_RestructuringReserveAccrualAdjustment [3]
Foreign currency translation   (674)us-gaap_RestructuringReserveTranslationAdjustment (31)us-gaap_RestructuringReserveTranslationAdjustment 452us-gaap_RestructuringReserveTranslationAdjustment
Ending balance 39,104us-gaap_RestructuringReserve 4,039us-gaap_RestructuringReserve 39,104us-gaap_RestructuringReserve 15,898us-gaap_RestructuringReserve
Less amounts reported in Accrued expenses 39,104us-gaap_RestructuringReserveCurrent [4] 4,039us-gaap_RestructuringReserveCurrent [4] 39,104us-gaap_RestructuringReserveCurrent [4] 14,428us-gaap_RestructuringReserveCurrent
Amounts reported in Other noncurrent liabilities $ 0us-gaap_RestructuringReserveNoncurrent $ 0us-gaap_RestructuringReserveNoncurrent $ 0us-gaap_RestructuringReserveNoncurrent $ 1,470us-gaap_RestructuringReserveNoncurrent
[1] The year ended December 31, 2014 includes charges amounting to $1.9 million for retention of certain employees associated with our antioxidant, ibuprofen and propofol businesses which were sold effective September 1, 2014. These workforce reduction charges are recorded in (Loss) income from discontinued operations (net of tax), in our consolidated statements of income.The year ended December 31, 2013 includes charges amounting to $33.4 million in connection with the announced realignment of our operating segments effective January 1, 2014 as described above.The year ended December 31, 2012 includes charges amounting to $21.6 million relating to reduction in force liabilities associated with our exit of the phosphorus flame retardants business noted above.
[2] In connection with the announced realignment of our operating segments effective January 1, 2014, in the fourth quarter of 2013 we initiated a workforce reduction plan which resulted in a reduction of approximately 230 employees worldwide. In the fourth quarter of 2013 we recorded charges of $33.4 million ($21.9 million after income taxes) for termination benefits and other costs related to this workforce reduction plan. Payments under this workforce reduction plan are substantially complete.
[3] Amounts reversed to income reflect adjustments based on actual timing and amount of final settlements.
[4] See Note 20, “Restructuring and Other.”